信隆健康(002105) - 2019 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2019 was ¥345,038,225.31, representing a 4.48% increase compared to ¥330,254,638.68 in the same period last year[8] - The net profit attributable to shareholders was -¥7,286,504.13, a decrease of 33.50% from -¥5,458,141.94 year-on-year[8] - The net profit for Q1 2019 was a loss of RMB 13,166,529.43, worsening by 53.37% from a loss of RMB 8,584,951.39 in Q1 2018[16] - The basic earnings per share were -¥0.020, a decline of 33.33% compared to -¥0.015 in the same period last year[8] - The diluted earnings per share were also -¥0.020, reflecting the same percentage decrease of 33.33%[8] - The net loss for Q1 2019 was CNY 13,166,529.43, compared to a net loss of CNY 8,584,951.39 in Q1 2018, reflecting a deterioration in performance[35] Cash Flow - The net cash flow from operating activities was ¥55,381,489.70, down 5.85% from ¥58,825,471.84 in the previous year[8] - The company’s cash and cash equivalents net increase was RMB 18,850,173.21, a decline of 64.53% from RMB 53,137,458.18 in the previous year[16] - Cash flow from operating activities generated a net cash inflow of ¥55,381,489.70, slightly down from ¥58,825,471.84 in the previous period[42] - Cash outflow from investing activities totaled ¥17,761,784.37, compared to ¥11,988,961.89 in the previous period, indicating a 48% increase[46] - Net cash flow from financing activities was -¥16,284,515.24, a decrease from a positive cash flow of ¥32,064,983.83 in the previous period[47] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,548,547,451.25, a decrease of 6.53% from ¥1,656,718,374.32 at the end of the previous year[8] - The company's total current assets decreased to CNY 860,971,039.92 from CNY 971,656,176.91, representing a reduction of about 11.4%[25] - The company's total liabilities decreased to CNY 993,967,264.79 from CNY 1,087,349,665.46, a reduction of about 8.6%[26] - The company's total assets decreased to CNY 1,234,869,164.10 as of March 31, 2019, down from CNY 1,334,494,088.37 at the end of 2018, a decline of approximately 7.4%[32] - Total liabilities stood at ¥1,087,349,665.46, remaining consistent with the previous period[51] Shareholder Information - The company had a total of 28,557 common shareholders at the end of the reporting period[11] - The largest shareholder, Litian Development Co., Ltd., held 41.93% of the shares, amounting to 154,522,500 shares[11] - The company reported no significant changes in its top ten shareholders, indicating stability in its ownership structure[21] Investment and Growth Strategy - The company plans to focus on mergers and acquisitions to enhance its industry chain integration and achieve external growth[21] - The company is currently evaluating potential investment opportunities in the rehabilitation equipment sector, aiming for strategic acquisitions[21] - Long-term equity investments increased by 70.16% to RMB 33,294,949.94, primarily due to a payment of RMB 15 million for investment in Wuhan Tianteng Power[16] Operating Costs and Expenses - Total operating costs for Q1 2019 were CNY 357,693,292.63, up from CNY 343,453,179.87 in the previous year, indicating an increase of about 4.2%[33] - Financial expenses rose by 2.33% to RMB 12,545,856.68 compared to RMB 12,259,965.60 in the previous year[16] - Research and development expenses for the current period were ¥3,621,679.84, a decrease from ¥4,047,778.57 in the previous period[37] - The company recorded a financial expense of ¥8,226,438.91, down from ¥9,716,593.50 in the previous period, with interest expenses at ¥3,538,298.09[37] Inventory and Receivables - Inventory decreased by 21.37% to RMB 219,281,645.22 from RMB 278,861,040.48 in the previous period[16] - Accounts receivable decreased to CNY 394,936,593.01 from CNY 448,813,628.00, indicating a decline of about 12.0%[24] - Inventory levels decreased to CNY 130,217,292.94 from CNY 179,897,718.38, reflecting a reduction of approximately 27.6%[29]